Literature DB >> 9988165

Histopathological and immunohistochemical studies of lesions associated with Ebola virus in a naturally infected chimpanzee.

M Wyers1, P Formenty, Y Cherel, L Guigand, B Fernandez, C Boesch, B Le Guenno.   

Abstract

Lesions caused by the Côte d'Ivoire subtype of Ebola virus in a naturally infected young chimpanzee were characterized by histopathological and immunohistochemical methods. The predominant lesions consisted of multifocal necrosis in the liver and diffuse fibrinoid necrosis in the red pulp of the spleen. In these sites, macrophages contained large eosinophilic intracytoplasmic inclusion bodies. Immunohistochemical staining indicated that macrophages were a major site of viral replication. The absence of bronchiolar and pulmonary lesions and the paucity of antigen-containing macrophages in the lung suggested that aerosol transmission by this animal was unlikely. There were necrotic foci and antigen-containing macrophages in intestinal lymph nodes, in association with lesions caused by intestinal parasites, suggesting the possibility of virus entry through the digestive tract.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988165     DOI: 10.1086/514300

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  20 in total

Review 1.  The Eosinophil in Infection.

Authors:  Karen A Ravin; Michael Loy
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 8.667

Review 2.  Ebola virus pathogenesis: implications for vaccines and therapies.

Authors:  Nancy Sullivan; Zhi-Yong Yang; Gary J Nabel
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

Review 3.  Ebola Vaccine: How Far are we?

Authors:  Rajani Sharma; Ketki Jangid
Journal:  J Clin Diagn Res       Date:  2017-05-01

4.  Enhancement of Ebola virus infection by seminal amyloid fibrils.

Authors:  Stephen M Bart; Courtney Cohen; John M Dye; James Shorter; Paul Bates
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

5.  Pathologic lesions in chimpanzees (Pan trogylodytes schweinfurthii) from Gombe National Park, Tanzania, 2004-2010.

Authors:  Karen A Terio; Michael J Kinsel; Jane Raphael; Titus Mlengeya; Iddi Lipende; Claire A Kirchhoff; Baraka Gilagiza; Michael L Wilson; Shadrack Kamenya; Jacob D Estes; Brandon F Keele; Rebecca S Rudicell; Weimin Liu; Sharon Patton; Anthony Collins; Beatrice H Hahn; Dominic A Travis; Elizabeth V Lonsdorf
Journal:  J Zoo Wildl Med       Date:  2011-12       Impact factor: 0.776

Review 6.  Natural pathology of the captive chimpanzee (Pan troglodytes): A 35-year review.

Authors:  Shyamesh Kumar; Hannah Laurence; Michael A Owston; R Mark Sharp; Priscilla Williams; Robert E Lanford; Gene B Hubbard; Edward J Dick
Journal:  J Med Primatol       Date:  2017-05-23       Impact factor: 0.667

7.  Ebola virus exploits a monocyte differentiation program to promote its entry.

Authors:  Osvaldo Martinez; Joshua C Johnson; Anna Honko; Benjamin Yen; Reed S Shabman; Lisa E Hensley; Gene G Olinger; Christopher F Basler
Journal:  J Virol       Date:  2013-01-23       Impact factor: 5.103

Review 8.  Immune barriers of Ebola virus infection.

Authors:  Anita K McElroy; Elke Mühlberger; César Muñoz-Fontela
Journal:  Curr Opin Virol       Date:  2018-02-16       Impact factor: 7.090

Review 9.  Neglected filoviruses.

Authors:  Robin Burk; Laura Bollinger; Joshua C Johnson; Jiro Wada; Sheli R Radoshitzky; Gustavo Palacios; Sina Bavari; Peter B Jahrling; Jens H Kuhn
Journal:  FEMS Microbiol Rev       Date:  2016-06-05       Impact factor: 16.408

10.  Ebola virus modulates transforming growth factor β signaling and cellular markers of mesenchyme-like transition in hepatocytes.

Authors:  Jason Kindrachuk; Victoria Wahl-Jensen; David Safronetz; Brett Trost; Thomas Hoenen; Ryan Arsenault; Friederike Feldmann; Dawn Traynor; Elena Postnikova; Anthony Kusalik; Scott Napper; Joseph E Blaney; Heinz Feldmann; Peter B Jahrling
Journal:  J Virol       Date:  2014-06-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.